D1 priming enhances both D1- and D2-mediated rotational behavior and striatal Fos expression in 6-hydroxydopamine lesioned rats-Reference-Cited by-同舟云学术

D1 priming enhances both D1- and D2-mediated rotational behavior and striatal Fos expression in 6-hydroxydopamine lesioned rats

Published:2010-01 Issue:3 Volume:94 Page:346-351
ISSN:0091-3057
Container-title:Pharmacology Biochemistry and Behavior
language:en
Short-container-title:Pharmacology Biochemistry and Behavior

Author:

Pollack Alexia E.,Thomas Lindsay I.

Funder

University of Massachusetts

Publisher

Elsevier BV

Subject

Behavioral Neuroscience,Biological Psychiatry,Clinical Biochemistry,Pharmacology,Toxicology,Biochemistry

Reference33 articles.

1. Rotation and striatal c-fos expression after repeated, daily treatment with selective dopamine receptor agonists and levodopa;Asin;J Pharmacol Exp Ther,1995

2. Effects of repeated D1 receptor stimulation on rotation and c-fos expression;Asin;Eur J Pharmacol,1993

3. Behavioural sensitization in 6-hydroxydopamine lesioned rats involves the dopamine signal transduction: changes in DARPP-32 phosphorylation;Barone;Neurosci,1994

4. Pharmacological analysis demonstrates dramatic alteration of D1 dopamine receptor neuronal distribution in the rat analog of L-DOPA-induced dyskinesias;Berthet;J Neurosci,2009

5. Chronic L-DOPA treatment in the unilateral 6-OHDA rat: evidence for behavioral sensitization and biochemical tolerance;Carey;Brain Res,1991

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Striatal Nurr1 Facilitates the Dyskinetic State and Exacerbates Levodopa-Induced Dyskinesia in a Rat Model of Parkinson's Disease;The Journal of Neuroscience;2020-04-01

2. Striatal Nurr1 Facilitates the Dyskinetic State and Exacerbates Levodopa-Induced Dyskinesia in a Rat Model of Parkinson’s Disease;2019-09-28

3. Performance of movement in hemiparkinsonian rats influences the modifications induced by dopamine agonists in striatal efferent dynorphinergic neurons;Experimental Neurology;2013-09

4. Tremorolytic effects of safinamide in animal models of drug-induced parkinsonian tremor;Pharmacology Biochemistry and Behavior;2013-04

5. Abnormal involuntary movement (AIM) expression following D2 dopamine agonist challenge is determined by the nature of prior dopamine receptor stimulation (priming) in 6-hydroxydopamine lesioned rats;Pharmacology Biochemistry and Behavior;2013-04